Drugs / Dendritic vaccine pulsed with multiple peptides
Dendritic vaccine pulsed with multiple peptides
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00766753 | Dec 2006 → Sep 2009 | malignant glioma | Frank Lieberman | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Dendritic vaccine pulsed with multiple peptides | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00766753 ↗ |
| Modality | Vaccine | “vaccinations with Type-1 alpha-DCs (alpha-DC1) loaded with glioma-associated antigen (GAA) epitopes” NCT00766753 ↗ |
| Route | Other | “four (4) injections of the vaccine into the lymph nodes” NCT00766753 ↗ |